Please assess the completion status of the following clinical trial:

Trial Title: Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Moderate or severe submental fat~* Dissatisfaction with submental area~* History of stable body weight~* Signed informed consent~Exclusion Criteria:~* Any medical or other condition that would affect subject safety or evaluation of efficacy~* Previous intervention in the submental area

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Participants received placebo administered in 0.2 mL injections, up to 10 mL per treatment session at intervals of approximately 1 month for up to a maximum of 6 treatments.
- Deoxycholic acid Injection 1 mg/cm² (Type: EXPERIMENTAL): Participants received deoxycholic acid 1 mg/cm² administered in 0.2 mL injections, up to 10 mL per treatment session at intervals of approximately 1 month for up to a maximum of 6 treatments.
- Deoxycholic acid Injection 2 mg/cm² (Type: EXPERIMENTAL): Participants received deoxycholic acid 2 mg/cm² administered in 0.2 mL injections, up to 10 mL per treatment session at intervals of approximately 1 month for up to a maximum of 6 treatments.

Based on this trial design, predict the completion outcome and termination type (if applicable).